Cancer Generics Market 2022 Cancer Generics Market 2022

Cancer Generics Market is Anticipated to
Witness a Double Digit Growth During 2022:
Radiant Insights, Inc
“This number is forecasted to increase to a value of
19.3 Million by 2025. Furthermore, the patent expiry
of blockbuster cancer drugs is another major factor
which is propelling the growth of the cancer generics
industry.”
Within the pharmaceutical industry, the oncology market is growing at a rapid pace owing to the
rising incidences of cancer. In 2015, 15.2 Million new cancer cases were registered across the
globe. This number is forecasted to increase to a value of 19.3 Million by 2025. Furthermore, the
patent expiry of blockbuster cancer drugs is another major factor which is propelling the growth of
the cancer generics industry.
"Global Cancer Generics Market Forecast to 2022", the global cancer generics market is anticipated
to witness a double digit growth during 2016-2022. This report provides a detailed analysis of the
current and future market scenario of the global cancer generics market. The report provides
insight about the major drivers and challenges, along with the latest trends and developments
impacting the industry growth. In addition, the report also highlights various opportunities
available for growth of the global cancer generics market.
Read Complete Report with TOC @ http://www.radiantinsights.com/research/global-
cancer-generics-market-forecast-to-2022
Follow Us: